99 related articles for article (PubMed ID: 35398759)
1. Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study.
Dieci MV; Azzarello G; Zagonel V; Bassan F; Gori S; Aprile G; Chiarion-Sileni V; Lonardi S; Oliani C; Zaninelli M; Chiari R; Favaretto A; Pavan A; Di Liso E; Mioranza E; Baldoni A; Bergamo F; Maruzzo M; Ziampiri S; Inno A; Graziani F; Sinigaglia G; Celestino M; Conte P; Guarneri V;
Eur J Cancer; 2022 May; 167():81-91. PubMed ID: 35398759
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.
Guarneri V; Bassan F; Zagonel V; Milella M; Zaninelli M; Cattelan AM; Vianello A; Gori S; Aprile G; Azzarello G; Chiari R; Favaretto A; Oliani C; Scola A; Pastorelli D; Mandarà M; Zustovich F; Bernardi D; Chiarion-Sileni V; Morandi P; Toso S; Di Liso E; Ziampiri S; Caccese M; Zampiva I; Puccetti O; Celestino M; Dieci MV; Conte P;
Eur J Cancer; 2021 Apr; 147():120-127. PubMed ID: 33647547
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
4. Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
; Pinato DJ; Patel M; Scotti L; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Bower M; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Ottaviani D; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Queirolo P; Cruz CA; Saoudi-Gonzalez N; Felip E; Roqué Lloveras A; Newsom-Davis T; Sharkey R; Roldán E; Reyes R; Zoratto F; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Berardi R; Giusti R; Mazzoni F; Guida A; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Tabernero J; Van Hemelrijck M; Diamantis N; Gennari A; Cortellini A
JAMA Oncol; 2022 Jan; 8(1):114-122. PubMed ID: 34817562
[TBL] [Abstract][Full Text] [Related]
5. Variation over Time in Child and Neighborhood Characteristics Associated with COVID-19.
Lang S; Silveira L; Smith C; Abuogi L; DeCamp LR
Health Equity; 2023; 7(1):676-684. PubMed ID: 37908402
[TBL] [Abstract][Full Text] [Related]
6. Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network.
Kodde C; Bonsignore M; Schöndube D; Bauer T; Hohenstein S; Bollmann A; Meier-Hellmann A; Kuhlen R; Nachtigall I
Infection; 2023 Feb; 51(1):119-127. PubMed ID: 35657531
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
Bauer KA; Puzniak LA; Yu KC; Finelli L; Moise P; Ai C; Watts JA; Gupta V
BMC Infect Dis; 2022 Nov; 22(1):841. PubMed ID: 36368931
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases.
Martin P; Tsourti Z; Ribeiro J; Castelo-Branco L; de Azambuja E; Gennatas S; Rogado J; Sekacheva M; Šušnjar S; Viñal D; Lee R; Khallaf S; Dimopoulou G; Pradervand S; Whisenant J; Choueiri TK; Arnold D; Harrington K; Punie K; Oliveira J; Michielin O; Dafni U; Peters S; Pentheroudakis G; Romano E
ESMO Open; 2023 Jun; 8(3):101566. PubMed ID: 37285719
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana.
Taylor K; Rivere E; Jagneaux T; LeBoeuf G; Estela K; Pierce C; O'Neal C
PLoS One; 2022; 17(10):e0268853. PubMed ID: 36269696
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
11. [Impact of COVID-19 on the immigrant population in the Veneto Region (Northern Italy), by geographical area of origin].
Ferroni E; Gennaro N; Barbiellini Amidei C; Avossa F; Maifredi G; Spadea T; Cacciani L; Silvestri C; Bartolini L; Petrelli A; Di Napoli A; Zorzi M;
Epidemiol Prev; 2022; 46(4):81-88. PubMed ID: 35862563
[TBL] [Abstract][Full Text] [Related]
12. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of hospitalized patients with SARS-CoV-2 infection during successive waves of the COVID-19 pandemic in a reference hospital in Spain.
Iftimie S; López-Azcona AF; Lozano-Olmo MJ; Hernández-Aguilera A; Sarrà-Moretó S; Joven J; Camps J; Castro A
Sci Rep; 2022 Oct; 12(1):17384. PubMed ID: 36253391
[TBL] [Abstract][Full Text] [Related]
14. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
[TBL] [Abstract][Full Text] [Related]
15. Meeting the Challenges in Cancer Care Management During the SARS-Cov-2 Pandemic: A Retrospective Analysis.
Rasschaert M; Vanclooster P; Depauw L; Mertens T; Roelant E; Coenen E; Anguille S; Janssens A; Van Dam P; Peeters M
Cancer Control; 2021; 28():10732748211045275. PubMed ID: 34623943
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP).
Zama D; Baccelli F; Colombini A; Contino A; Calore E; Petris MG; Meneghello L; Mercolini F; Lo Vecchio A; Montalto S; Meazza C; Barone A; Compagno F; Muggeo P; Soncini E; Brescia L; Giraldi E; Giurici N; Mura RM; Cellini M; Perruccio K; Petroni V; La Spina M; Ziino O; Burnelli R; De Santis R; Mascarin M; Barretta V; Tridello G; Cesaro S
Ann Hematol; 2022 Aug; 101(8):1843-1851. PubMed ID: 35726104
[TBL] [Abstract][Full Text] [Related]
17. Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy.
Grau JJ; Palmero R; Marmol M; Domingo-Domenech J; Monzo M; Fuster J; Vidal O; Fondevila C; Garcia-Valdecasas JC
World J Surg Oncol; 2006 Aug; 4():53. PubMed ID: 16904003
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
